Separation of mediastinal shed blood during aortic valve surgery elicits a reduced inflammatory response

Journal of Cardiovascular Medicine

Volumn 17, Issue 1, 2016, Pages 62-68

  Bisleri, Gianluigi ^a   Tononi, Laura ^a   Morgan, Jeffrey A ^b   Bordonali, Tania ^c   Cheema, Faisal H ^d   Siddiqui, Osama T ^e   Repossini, Alberto ^a   Rosati, Fabrizio ^a   Muneretto, Claudio ^a  

^a SSVD Allergologia   (Italy)

^b HENRY FORD HOSPITAL   (United States)

^c UNIVERSITY OF BRESCIA   (Italy)

^d Columbia College of Physi and Surg ^*  (United States)

^e AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

aortic valve; cardiopulmonary bypass; inflammation; shed blood; surgery

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; AUTACOID; BIOLOGICAL MARKER; CYTOKINE;

ADULT; AGED; AORTA CLAMPING; AORTA VALVE REPLACEMENT; ARTICLE; ATRIAL FIBRILLATION; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL STUDY; DEMOGRAPHY; FEMALE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INFLAMMATION; LEUKOCYTOSIS; MALE; OUTCOME ASSESSMENT; OXYGENATOR; PERICARDIAL EFFUSION; POSTOPERATIVE CARE; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; PROTEIN SECRETION; VERY ELDERLY; ADVERSE EFFECTS; AORTA VALVE; BLOOD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICES; EQUIPMENT DESIGN; HEART VALVE REPLACEMENT; METABOLISM; MIDDLE AGED; PROCEDURES; SURGERY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AORTIC VALVE; BIOMARKERS; C-REACTIVE PROTEIN; CARDIOPULMONARY BYPASS; CYTOKINES; EQUIPMENT DESIGN; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 84948575724     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0000000000000017     Document Type: Article

References (18)

1. Asimakopoulos G, Taylor KM. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. Ann Thorac Surg 1998; 66:2135-2144.
2. Vohra HA, Whistance R, Modi A, Ohri SK. The inflammatory response to miniaturised extracorporeal circulation: A review of the literature. Mediators Inflamm 2009; 2009:707042.
3. Ascione R, Lloyd CT, Underwood MJ, Lotto AA, Pitsis AA, Angelini GD. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. Ann Thorac Surg 2000; 69:1198-1204.
4. Paparella D, Yau TM, Young E. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002; 21:232-244.
5. Seghaye M, Duchateau J, Bruniaux J, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg 1996; 111:545-553.
6. Wi HJ. Extracorporeal circulation: The response of humoral and cellular elements of blood to extracorporeal circulation. In: Cohn LH, editor. Cardiac surgery in the adult. New York: McGraw-Hill; 2008. pp. 370-389.
7. DeSomer F, Van BY, Caes F, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion 2002; 17:39-44.
8. Khosravi A, Skrabal CA, Westphal B, et al. Evaluation of coated oxygenators in cardiopulmonary bypass systems and their impact on neurocognitive function. Perfusion 2005; 20:249-254.
9. Fromes Y, Gaillard D, Ponzio O, et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. Eur J Cardiothorac Surg 2002; 22:527-533.
10. Song J, Park J, Kim JY, et al. Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: A randomized double-blinded study. Korean J Anesthesiol 2013; 64:334-340.
11. Chen TT, Jiandong-Liu. Wang G, Jiang SL, Li LB, Gao CQ. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery. Heart Surg Forum 2013; 16:E38-E47.
12. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation 1995; 92:1487-1493.
13. Bical OM, Fromes Y, Gaillard D, et al. Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery. Eur J Cardiothorac Surg 2006; 29:699-702.
14. Franke A, Lante W, Fackeldey V, et al. Pro-inflammatory cytokines after different kinds of cardio-Thoracic surgical procedures: is what we see what we know? Eur J Cardiothorac Surg 2005; 28:569-575.
15. Lindon J, McManama G, Kushner L, Merrill EW, Salzman EW. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? Blood 1986; 68:355-362.
16. Gram J, Janetzko T, Jespersen J, Bruhn HD. Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of postsurgical bleeding. Thromb Haemost 1990; 63:241-245.
17. Butler J, Parker D, Pillai R, Westaby S, Shale DJ, Rocker GM. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. J Thorac Cardiovasc Surg 1993; 105:25-30.
18. Ohata T, Mitsuno M, Yamamura M, et al. Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting. J Artif Organs 2007; 10:92-95.